Olympus Innovation Ventures
San Jose, California, United StatesFounded 2021
Olympus Innovation Ventures (OIV) is the corporate venture capital arm of Olympus Corporation of the Americas, investing in customer-driven MedTech solutions across medical devices, diagnostics, and digital health, with a focus on gastrointestinal, urology, and respiratory therapeutic areas.
Their most common stage is series-a (50% of deals). Average disclosed round size is $24.9M (across 6 rounds with reported amounts).
Portfolio
5
Fund Size
$150M
Top Stage
Series A
Last 12 Mo
1
Team
YS
Yasuko Shusa
Venture Investment Lead
AH
Abigail Hunter-Syed
Head of Olympus Innovation Ventures
CM
Christos Monovoukas
Built and led Olympus Innovation Ventures
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| MMaxQ Medical | Series A | $31.5M | Aug 2026 |
| MMaxQ Medical | Series A | $31.5M | Jan 2026 |
 Alimetry | Series A | $18M | Oct 2024 |
 On Target Labs | Series C | $30M | Nov 2023 |
| OOn Target Laboratories | Series C | $30M | Nov 2023 |
| EEximis | Series B | $8.7M | — |
Top Co-Investors
3B Future Health Fund2 shared
Elevate Ventures2 shared
S3 Ventures2 shared
H.I.G. Growth Partners1 shared
H.I.G. BioHealth Partners1 shared
Touchdown Ventures1 shared
GD11 shared
Last updated: 19 September 2026